Crinetics Pharmaceuticals
Présence
Crinetics Pharmaceuticals fait partie des...
Crinetics Pharmaceuticals est une société cotée sous le symbole boursier CRNX (US).
Dirigeants
Voir l'organigramme avec ses 21 principaux dirigeants
Biographies les plus recherchées chez Crinetics Pharmaceuticals
- Scott Struthers, Chief Executive Officer and Director
- Camille Bedrosian, Director
- Wendell Wierenga, Chairman of the Board
Créer une alerte
pour suivre les mouvements de dirigeants chez Crinetics Pharmaceuticals.
Pharmacie
Crinetics Pharmaceuticals a 1 861 concurrents dont Pfizer (Etats—Unis), Sanofi (France) et Johnson & Johnson (Etats—Unis).
Actualités en fusion/acquisition en Pharmacie.
- MedMen has filed for bankruptcy protection (publié le 28 avril 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publié le 23 mars 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publié le 19 mars 2024).
Contacts en Pharmacie
Actualités
Derniers communiqués de presse par Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Receives Rare Pediatric Disease Designation from FDA for CRN04777 for the Treatment of Congenital Hyperinsulinism - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Provides New Data from Paltusotine and ACTH Antagonist Development Programs at European Congress of Endocrinology - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals to Participate in September Investor Conferences - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides Corporate Update - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Receives Orphan Drug Designation for Paltusotine for the Treatment of Acromegaly - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Confirms Completion for Half of the Enrolled Patients in the Ongoing Phase 2 ACROBAT Edge Clinical Trial for Paltusotine - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Appoints Adriana Cabré, MBA, as Vice President of Human Resources - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate Update - Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Crinetics Pharmaceuticals
- Voir plus de communiqués de presse Close
Réseaux sociaux à propos de Crinetics Pharmaceuticals
- Crinetics Pharmaceuticals sur Wikipédia, Google News & Yahoo Finance en 1-click
- Crinetics Pharmaceuticals sur LinkedIn, Twitter & YouTube en 1-click
